Study guide
10.2 Case Follow-up and Review
NBCE Part III Examination Exam
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current Exam Facts 1.2 TMCQ, EMCQ, and DXI Formats 1.3 Study Plan and Timed Pacing
2 Case History: Complaint and Background
2.1 Chief Complaint 2.2 Present Illness (HPI) 2.3 Past History
3 Case History: Context and Systems Review
2.4 Family History 2.5 Personal and Social History 2.6 Review of Systems
4 Physical Examination: Core Systems
3.1 General Survey 3.2 Head and Neck Examination 3.3 Thorax and Lung Examination 3.4 Cardiovascular Examination
5 Physical Examination: Specialized Regions
3.5 Breast and Axilla Examination 3.6 Abdominal Examination 3.7 Urogenital Examination 3.8 Rectal Examination
6 Neuromusculoskeletal Examination
4.1 Posture and Gait Analysis 4.2 Spinal and Extremity Orthopedic Procedures 4.3 Standard Neurological Testing 4.4 Peripheral Vascular Examination
7 Diagnostic Imaging (Clinical Domain)
5.1 Imaging Indications and Contraindications 5.2 Patient Protection and Positioning 5.3 Normal Imaging Anatomy 5.4 Description and Interpretation of Images
8 Clinical Laboratory: Core Studies
6.1 Urinalysis 6.2 Hematology 6.3 Serology 6.4 Blood Chemistries
9 Clinical Laboratory: Special Studies
6.5 Stool Analysis 6.6 Joint Fluid Analysis 6.7 Electrophysiologic Recordings (EEG, ECG, EMG, and NCV)
10 Diagnosis or Clinical Impression
7.1 Clinical Impression from History 7.2 Clinical Impression from Physical and NMS Exam 7.3 Clinical Impression from Diagnostic Imaging 7.4 Clinical Impression from Lab and Special Studies
11 Chiropractic Techniques
8.1 Indications and Contraindications for Chiropractic Care 8.2 Spinal Adjustive Techniques 8.3 Extremity Adjustive Techniques 8.4 Skeletal Biomechanics
12 Supportive Interventions: Modalities, Nutrition, Exercise
9.1 Physiotherapy Modalities 9.2 Nutrition and Diet 9.3 Corrective Exercises and Rehabilitation
13 Supportive Interventions: Ergonomics, Education, Wellness
9.4 Protective Body Mechanics and Ergonomics 9.5 Patient Education and Self-Care 9.6 Wellness and Lifestyle Counseling
14 Case Management
10.1 Treatment Plan and Prognosis 10.2 Case Follow-up and Review 10.3 Patient Referral and Co-Management 10.4 Clinical Documentation and Informed Consent
15 DXI: Arthritic Disorders
11.1 DXI Degenerative Arthritic Disorders 11.2 DXI Inflammatory Arthritic Disorders 11.3 DXI Metabolic and Crystalline Arthropathy
16 DXI: Congenital Anomalies and Skeletal Variants
12.1 DXI Spinal Congenital Anomalies 12.2 DXI Extraspinal Skeletal Variants 12.3 DXI Scoliosis Imaging
17 DXI: Trauma
13.1 DXI Skeletal Trauma 13.2 DXI Soft Tissue Trauma
18 DXI: Tumors and Tumor-like Processes
14.1 DXI Benign Bone Tumors 14.2 DXI Primary Malignant Bone Tumors 14.3 DXI Metastatic Bone Disease 14.4 DXI Tumor-like Processes
19 DXI: Miscellaneous Osteoarticular
15.1 DXI Hematological and Vascular Bone Disease 15.2 DXI Bone and Joint Infections 15.3 DXI Nutritional and Metabolic Bone Disease 15.4 DXI Endocrine Bone Disease
20 DXI: Soft Tissue
16.1 DXI Chest Soft Tissue Findings 16.2 DXI Abdomen Soft Tissue Findings 16.3 DXI Miscellaneous Soft Tissue Findings
21 Exam Strategy and Common Traps
17.1 EMCQ Case Strategy 17.2 Timed Exam Strategy and Common Traps
10.2 Case Follow-up and Review
Key Takeaways Explain This Topic AI
Reassessment must occur at planned intervals (commonly every 2 weeks or every 4-12 visits) using objective, repeatable measures compared against a documented baseline
The continue/change/stop decision is driven by the trend in objective findings relative to expected timelines, not by patient request alone or by visit count alone
Validated outcome measures (VAS/NRS, Oswestry Disability Index, Neck Disability Index, Patient-Specific Functional Scale, Global Rating of Change) provide the objective basis for reassessment
A lack of meaningful improvement after a reasonable trial of care (typically 2-4 weeks or 6-12 visits) requires the plan to be modified, the diagnosis reconsidered, or the patient referred - not simply continued unchanged
New or worsening red-flag findings at any reassessment point override the existing plan and require immediate action, regardless of where the patient is in the treatment course
Last updated: July 2026
Case Follow-up and Review
Quick Answer: Follow-up care is not simply repeating the initial treatment - it requires scheduled reassessment against objective outcome measures, followed by a deliberate decision to continue, modify, or discontinue care. NBCE Part III vignettes commonly present a patient at a reassessment point and ask what the doctor should do next based on the trend in the data, not the raw current symptom level alone.
When and Why to Reassess
Reassessment should be built into the treatment plan from the outset, not triggered only when a patient fails to improve. Common reassessment triggers include:
Scheduled intervals - e.g., every 2 weeks, or after a defined number of visits (commonly 4, 6, or 12 visits depending on condition severity)
- End of a care phase - transitioning from relief to corrective care, or corrective to supportive care
- Plateau or lack of expected progress - symptoms or function stop improving despite continued care
- New symptoms or a change in clinical presentation - any new complaint, neurological change, or red flag
- Patient-reported worsening - regardless of where this falls in the planned schedule
At each reassessment, findings must be compared to the documented baseline recorded at the initial visit. Without a baseline, no meaningful comparison is possible, which is why thorough initial documentation (see Section 10.4) is a prerequisite for defensible follow-up.
Objective Outcome Measures
Outcome measures give reassessment a quantifiable, reproducible basis rather than relying on subjective impressions alone.
Outcome Measure What It Assesses Common Use
Visual Analog Scale (VAS) / Numeric Rating Scale (NRS) Current pain intensity (0-10 or 0-100mm) Any condition; tracked at every visit or reassessment
- Oswestry Disability Index (ODI) Functional disability from low back pain Low back conditions
- Neck Disability Index (NDI) Functional disability from neck pain Cervical spine conditions
Patient-Specific Functional Scale (PSFS) Patient-identified functional activities and their limitation Any musculoskeletal condition, individualized
Global Rating of Change (GROC) Patient's overall perceived change since baseline Supplemental measure at reassessment
Range of motion (goniometry/inclinometry) Objective joint mobility Spinal and extremity conditions
Orthopedic/neurological test findings Objective sign changes (e.g., SLR angle, reflex, sensory findings) Conditions with a positive baseline finding
A meaningful clinical improvement is typically defined as a change exceeding the minimal clinically important difference (MCID) for the given instrument - a small numeric change within measurement error should not be interpreted as clinically meaningful improvement.
The Continue / Change / Stop Decision Framework
At each reassessment point, the clinical response should be categorized, and the plan updated accordingly:
Clinical Response Interpretation Appropriate Action
Improving as expected Progressing toward stated goals on schedule Continue current plan; proceed toward phase transition or discharge
Improving, slower than expected Some progress, not on the projected timeline Modify plan - adjust frequency, add or change adjunctive care, extend timeline with documented justification
Plateaued No meaningful change across two or more consecutive reassessments Reconsider the working diagnosis, change the treatment approach, or refer if a prior modification already failed
No improvement after a reasonable trial No meaningful change from baseline after roughly 2-4 weeks or 6-12 visits Discontinue the current approach; reconsider diagnosis; referral strongly considered
Worsening Symptoms, function, or objective findings decline Stop or substantially alter current care; re-screen for red flags; refer as indicated
New red flags at any point Findings suggest a serious or non-musculoskeletal condition Stop manual care immediately; refer urgently (see Section 10.3)
The "reasonable trial" concept is central to defensible case management: conservative care is expected to produce objectively measurable improvement within a bounded period. Continuing an unmodified plan indefinitely in the absence of that improvement - simply because the patient tolerates it or requests it - is not clinically supportable and is a common wrong-answer trap in exam vignettes.
Maximum Therapeutic Benefit and Discharge
A patient reaches maximum therapeutic benefit (MTB) when objective measures plateau and further care is not expected to produce additional meaningful improvement. MTB is distinct from full resolution: a patient can reach MTB with residual findings (e.g., mild persistent stiffness) if repeated trials of modified care produce no further gains. At MTB, appropriate next steps include:
Discharge to self-management - home exercise, activity modification, education on recurrence prevention
Transition to supportive/wellness care - only when a documented history of recurrence or an underlying chronic/degenerative condition justifies periodic visits
Referral - when residual findings suggest a condition outside the scope or effectiveness of chiropractic care alone
Documenting the Reassessment
Each reassessment note should explicitly state: the outcome measure(s) used, the current value compared to baseline and the prior reassessment, the clinical interpretation of that trend, and the resulting decision (continue, modify, discharge, or refer) with rationale. This creates the audit trail that demonstrates care was continuously justified by objective findings rather than delivered on autopilot - a standard that applies equally to clinical defensibility and third-party payer review of medical necessity.